Premium
TetraLogic Pharmaceuticals Corporation (CE) (TLOG)
USOTC
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
PAOLI, Pa., Nov. 02, 2016 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) (“TetraLogic” or “Company”), a clinical-stage biopharmaceutical company focused on...
Biotechnology Stocks on our Radar -- Array BioPharma, PDL BioPharma, Advaxis, and TetraLogic Pharma PR Newswire NEW YORK, June 16, 2016 NEW YORK, June 16, 2016 /PRNewswire/ -- On Wednesday, June...
Birinapant Shows No Activity in Randomized Phase 2 MDS Study SHAPE Shows Clinical Benefit in Randomized Phase 2 CTCL Study MALVERN, Pa., Jan. 06, 2016 (GLOBE NEWSWIRE) -- TetraLogic...
MALVERN, Pa., Nov. 9, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that two abstracts discussing clinical data on birinapant will be presented at...
MALVERN, Pa., Nov. 4, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
MALVERN, Pa., Nov. 2, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it has an open U.S. Investigational New Drug application in support of a...
Updates on MDS Clinical Program - Free Research Report on TetraLogic Pharmaceuticals Corporation PR Newswire NEW YORK, July 15, 2015 NEW YORK, July 15, 2015 /PRNewswire/ -- ACI Association has...
MALVERN, Pa., May 6, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
MALVERN, Pa., May 6, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
MALVERN, Pa., May 1, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 29841 | 1.28E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 21378 | 1.23E-6 | CS |
| 52 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 13405 | 1.23E-6 | CS |
| 156 | -0.004999 | -99.98 | 0.005 | 0.006 | 1.0E-6 | 11409 | 0.00169225 | CS |
| 260 | -0.039999 | -99.9975 | 0.04 | 0.06 | 1.0E-6 | 31744 | 0.02034855 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| RONNRonn Motor Group Inc (PK) | US$ 0,0002 (-33,33%) | 106,65M |
| ENDVEndonovo Therapeutics Inc (PK) | US$ 0,0002 (-20,00%) | 83,71M |
| IDVVInternational Endeavors Corporation (PK) | US$ 0,0004 (0,00%) | 83,41M |
| HCMCHealthier Choices Management Corporation (PK) | US$ 0,000001 (-99,00%) | 79,35M |
| RDARRaadr Inc (PK) | US$ 0,0006 (0,00%) | 70,87M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
